Bronchial artery embolisation for the management of haemoptysis in patients with pulmonary tuberculosis

• DOI: 10.5588/ijtld.10.0659
• Publication Date: 2011-07-11T11:01:58Z
• Authors: B. S. Shin; G. S. Jeon; S. A. Lee; M-H. Park
• Keywords: Bronchial artery; Mycetoma

To evaluate immediate and long-term outcomes of bronchial artery embolisation (BAE) for the treatment haemoptysis in patients with pulmonary tuberculosis (TB), to clarify factors that influence recurrence.Of 398 who underwent BAE between January 2004 June 2009, 169 were retrospectively reviewed. All had either a history TB or current diagnosis TB. Follow-up ranged from 1 day 66 months.Haemoptysis was stopped markedly decreased, subsequent clinical improvement, 163 (96.4%); 50 symptoms recurred during follow-up period. Disease activity, aortography mycetoma showed statistically significant correlation recurrence rate. Cumulative non-recurrence rates 76.1% 12 months 51.4% 40 months. The median time 41.2 activity early recurrence. Only one major complication observed.BAE is safe effective option control patients. both correlate higher rate